摘要
一氧化氮(NO),作为一个重要的信号分子,参与诸如心血管稳态、神经传导,免疫调节,和肿瘤的生长等生理过程。因此,不同种类的NO药物包括diazeniumdiolates,S-亚硝基硫醇,亚硝酰,硝基苯等等已经被开发应用。然而,这些低分子量的NO供体已因突发释放,低载荷和无靶点传递问题限制了其临床应用。基于生物材料的载体的NO传递提供了一个有益的策略,实现了NO对靶组织或器官的控制和持续传递。确切来说,通过物理、化学手段或超分子技术,NO供体药物前体已贴装不同的材料来制备纳米颗粒,凝胶,和涂层的平台。这些NO释放的生物材料广泛应用于治疗缺血性疾病、癌症和心血管疾病和伤口愈合的治疗。首先,没有释放的生物材料表面涂层可以模拟血管内皮细胞的生理功能,从而促进血管生成及改善心血管植入物的通畅。其次,因为NO也介导了许多发生在皮肤损伤后的重要过程,无释放的生物材料可以作为理想的伤口敷料,以加速组织再生。最后,生物材料使高剂量的NO传递到肿瘤,从而产生有效的抗肿瘤作用。在这篇综述中,我们将总结不同的NO释放生物材料的进展,并强调他们的生物医学应用,希望能够激发有关生物材料为基础的NO传递系统新的观点。
关键词: 一氧化氮,生物材料,控制交货,生物医学应用,心血管疾病,癌症。
Current Medicinal Chemistry
Title:Nitric Oxide-Releasing Biomaterials for Biomedical Applications
Volume: 23 Issue: 24
Author(s): Xin Zhou, Jimin Zhang, Guowei Feng, Jie Shen, Deling Kong, Qiang Zhao
Affiliation:
关键词: 一氧化氮,生物材料,控制交货,生物医学应用,心血管疾病,癌症。
摘要: Nitric oxide (NO), as an essential signaling molecule, participates in various physiological processes such as cardiovascular homeostasis, neuronal transmission, immunomodulation, and tumor growth. The multiple role of NO in physiology and pathophysiology has triggered a massive interest in the strategies of delivering exogenous NO for biomedical applications. Hence, different kinds of NO prodrugs have been developed up to date, including diazeniumdiolates, S-nitrosothiol, metal-nitrosyl, nitrobenzene, and so on. However, the clinical application of these low molecular weight NO donors has been restricted due to the problems of burst release, low payloads, and untargeted delivery. The delivery of NO by biomaterialbased carrier offers a beneficial strategy to realize the controlled and sustained delivery of NO to the targeted tissues or organs. In detail, NO-donor prodrugs have been attached and loaded to diverse biomaterials to fabricate nanoparticles, hydrogels, and coating platforms by means of physical, chemical, or supramolecular techniques. These NO-releasing biomaterials hold promise for a number of biomedical applications ranging from therapy of the ischemic disease and several types of cancer to cardiovascular devices and wound dressing. First, surface coating with NO-releasing biomaterials could mimic the physiological function of vascular endothelium, therefore promoting vascularization and improving the patency of cardiovascular implants. Next, because NO also mediates many important processes that take place after cutaneous injury, NO-releasing biomaterials could serve as ideal wound dressing to accelerate tissue regeneration. Finally, biomaterials enable localized delivery of high dose of NO to tumors in a sustained manner, thus generating potent tumoricidal effect. In this review, we will summarize the progress of different NO-releasing biomaterials, and highlight their biomedical applications with a hope to inspire new perspectives in the area of biomaterial-based NO-delivery systems.
Export Options
About this article
Cite this article as:
Xin Zhou, Jimin Zhang, Guowei Feng, Jie Shen, Deling Kong, Qiang Zhao , Nitric Oxide-Releasing Biomaterials for Biomedical Applications, Current Medicinal Chemistry 2016; 23 (24) . https://dx.doi.org/10.2174/0929867323666160729104647
DOI https://dx.doi.org/10.2174/0929867323666160729104647 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Uric Acid and Diabetes: Is there a Link?
Current Pharmaceutical Design Interrelationship Between Periapical Lesion and Systemic Metabolic Disorders
Current Pharmaceutical Design Bioactive Small Molecules in the Pathogenesis and Pharmacology of Cardiovascular Diseases: From Bench to Bedside
Current Topics in Medicinal Chemistry Heart Failure with Preserved Ejection Fraction: Entresto a Possible Option
Cardiovascular & Hematological Disorders-Drug Targets Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders
Central Nervous System Agents in Medicinal Chemistry Editorial (Hot Topic: Novel Biomarkers in the Prognosis, Progression and Treatment of Cardiovascular Disease: The Role of microRNAs )
Current Topics in Medicinal Chemistry Nanoparticle Based Treatment for Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Short-term RR-Interval Power Spectral Analysis as a New Tool to Stratify the Risk of Sudden Death in Various Cardiovascular Conditions
Vascular Disease Prevention (Discontinued) Cardiovascular Aspect of Beta-Thalassaemia
Cardiovascular & Hematological Agents in Medicinal Chemistry 24-Hour Blood Pressure Control – A Predictor for Clinical Outcomes
Current Hypertension Reviews QTc Prolongation to Predict Mortality in Patients Admitted with COVID-19 Infection: An Observational Study
Current Vascular Pharmacology Serum Levels of Fibroblast Growth Factor 23 in People Living with HIV
Current HIV Research Are the Pleiotropic Effects of Telmisartan Clinically Relevant?
Current Pharmaceutical Design GH Supplementation Effects on Cardiovascular Risk in GH Deficient Adult Patients: A Systematic Review and Meta-analysis
Endocrine, Metabolic & Immune Disorders - Drug Targets Passive Smoking and Coronary Heart Disease
Current Vascular Pharmacology Omega-3 Polyunsaturated Fatty Acids and Cancer
Anti-Cancer Agents in Medicinal Chemistry Associations between Adiponectin Gene Variability, Proinflammatory and Angiogenetic Markers: Implications for Microvascular Disease Development in Type 2 Diabetes Mellitus?
Current Vascular Pharmacology Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19)
Current Pharmaceutical Design Targeting Gender Difference in the Introduction of New Drugs for Diabetes Mellitus and Metabolic Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)